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Backgrounds 
 Hypertension: No.1 global health risk (WHO, 2009). 
 Good BP control reduced CVD events (Chobanian.2003).   
 BP control: not successful (Lewis. 2010; Setiati & Sutrisna, 2005; Wu  2009).  
 Doctor factor: barrier in BP control (Ogedegbe, 2008; Rose, 2009). 
 Feedback improved DR’s RX behavior (Ziemer, 2006) ,    
the therapy intensification & BP control (Lűders, 2010). 
 The non-pharmacological intervention effect: 
heterogenic-inconsistent, and not predictably 
effective. The most effective intervention is 
unknown (Glynn, 2010; Doggrell 2010). 
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Aims 
To assess the effect of the feedback 
intervention to physicians on the systolic 
blood pressure among hypertension 
subjects. 
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Characteristics 
Intervention 
(n=385) 
Non-intervention 
(n=271) 
Male (%)ǂ 41.6 44.2 
Comorbid (%)ǂ* 78.7 91.5 
Age (years) 64.1±10.1 64.2±8.8 
Baseline SBP (mmHg)* 144.1±15.8 139.6±13.8 
Baseline DBP (mmHg) 85.8±9.5 85.7±8.5 
Mean SBP (mmHg) 141.6±12.2 142.0±12.9 
Mean DBP (mmHg)* 84.6±6.7 85.8±7.1 
Visit Frequency  4.8±1.4 4.6±1.4 
* Significantly different between group;  ǂ chi-square test 
Table 1. Baseline/Period 1 Profiles of the Intervention and  
               Non-Intervention Subjects 
RESULTS & DISCUSSION 
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Characteristics 
Intervention 
(n=385) 
Non-intervention 
(n=271) 
Sig. 
Final SBP (mmHg) 138.2±17.2 140.6±15.4 0.07 
Final DBP (mmHg) 83.0±9.5 84.2±8.9 0.09 
Mean SBP (mmHg) 140.4±10.8 140.6±10.0 0.79 
Mean DBP (mmHg)* 83.6±6.1 84.8±6.3 0.02 
Final–Target SBP (mmHg)* -6.1±17.3 -9.6±15.5 <0.01 
Mean–Target SBP (mmHg) -8.3±11.5 -9.7±10.4 0.12 
Final–Baseline SBP (mmHg)* 5.9±20.3 -0.9±20.0 <0.01 
Final– Mean SBP (mmHg)* 2.2±13.6 0.1±13. 0.79 
* significantly different between groups  
Table 2. Post-Intervention Profile and the Reduction of Blood Pressure 
between Intervention vs. Non-Intervention Subjects 
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The monthly SBPs between groups were not different with repeated 
measurement Anova (p>0.05) 
Odds Ratio (OR) 
Controlled SBP of Intervention vs. 
Non-Intervention Subjects 
Final SBP:  OR 1.4(CI95%:1.0-1.9) 
Mean SBP: OR 1.6(CI95%:1.1-2.3) 
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CONCLUSION 
BP feedback intervention to doctors 
improved SBP control based on : ∆final and 
baseline SBP, ∆final and target SBP, ∆final 
and mean SBP (p<0.05); and odds ratio 
mean SBP reached the target vs. non-
intervention subjects. 
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